Evidence of meaningful levels of Trypanosoma cruzi in platelet concentrates from seropositive blood donors

Transfusion

Volumn 55, Issue 6, 2015, Pages 1249-1255

  Cancino Faure, Beatriz ^a   Fisa, Roser ^a   Riera, Cristina ^a   Bula, Ibeth ^a   Girona Llobera, Enrique ^b,c   Jimenez Marco, Teresa ^b,c  

^a UNIVERSITY OF BARCELONA   (Spain)

^b Fundació Banc de Sang I Teixits de Les Illes Balears   (Spain)

^c UNIVERSITAT DE LES ILLES BALEARS   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

PROTOZOAL DNA; THROMBOCYTE CONCENTRATE;

APHERESIS; ARGENTINA; ARTICLE; BLOOD COMPONENT; BLOOD DONOR; BLOOD TRANSFUSION; BOLIVIA; CONTROLLED STUDY; ECUADOR; HUMAN; MAJOR CLINICAL STUDY; PARASITE LOAD; PARASITEMIA; PROSPECTIVE STUDY; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SEROLOGY; TRYPANOSOMA CRUZI; VENEZUELA; ADULT; BLOOD; CHAGAS DISEASE; DEVICES; ENDEMIC DISEASE; ETHNOLOGY; GENETICS; ISOLATION AND PURIFICATION; LEUKAPHERESIS; MIGRANT; PARASITOLOGY; SOUTH AMERICA; SPAIN; THROMBOCYTE; THROMBOCYTOPHERESIS;

ADULT; BLOOD DONORS; BLOOD PLATELETS; CHAGAS DISEASE; DNA, PROTOZOAN; EMIGRANTS AND IMMIGRANTS; ENDEMIC DISEASES; HUMANS; LEUKOCYTE REDUCTION PROCEDURES; PARASITEMIA; PLATELETPHERESIS; REAL-TIME POLYMERASE CHAIN REACTION; SOUTH AMERICA; SPAIN; TRYPANOSOMA CRUZI;

EID: 84930864475     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/trf.12989     Document Type: Article

References (31)

1. Pereira BI, Nazareth C, Malcata L, et al. Transfusion-transmitted protozoal infections: what is the risk in non-endemic countries? Acta Med Port 2011;24(Suppl 4):897-906.
2. Castro E. Chagas' disease: lessons from routine donation testing. Transfus Med 2009;19:16-23.
3. Bern C, Montgomery SP, Katz L, et al. Chagas disease and the US blood supply. Curr Opin Infect Dis 2008;21:476-82.
4. Benjamin RJ, Stramer SL, Leiby DA, et al. Trypanosoma cruzi infection in North America and Spain: evidence in support of transfusion transmission. Transfusion 2012;52:1913-21.
5. Young C, Losikoff P, Chawla A, et al. Transfusion-acquired Trypanosoma cruzi infection. Transfusion 2007;47:540-4.
6. Cimo PL, Luper WE, Scouros MA. Transfusion-associated Chagas' disease in Texas: report of a case. Tex Med 1993;89:48-50.
7. Grant IH, Gold JW, Wittner M, et al. Transfusion-associated acute Chagas disease acquired in the United States. Ann Intern Med 1989;111:849-51.
8. Nickerson P, Orr P, Schroeder ML, et al. Transfusion-associated Trypanosoma cruzi infection in a non-endemic area. Ann Intern Med 1989;111:851-3.
9. Cardo LJ, Asher L. Transfusion medicine illustrated. Electron micrographic study of the removal of Trypanosoma cruzi from blood products by leukodepletion filters. Transfusion 2006;46:1067-8.
10. Moraes-Souza H, Bordin JO, Bardossy L, et al. Prevention of transfusion-associated Chagas' disease: efficacy of white cell-reduction filters in removing Trypanosoma cruzi from infected blood. Transfusion 1995;35:723-6.
11. Kessler DA, Shi PA, Avecilla ST, et al. Results of lookback for Chagas disease since the inception of donor screening at New York Blood Center. Transfusion 2013;53:1083-7.
12. Blajchman MA. The clinical benefits of the leukoreduction of blood products. J Trauma 2006;60(Suppl 6):S83-90.
13. Duffy T, Cura CL, Ramirez JC, et al. Analytical performance of a multiplex real-time PCR assay using TaqMan probes for quantification of Trypanosoma cruzi satellite DNA in blood samples. PLoS Negl Trop Dis 2013;7:e2000
14. Riera C, Verges M, Iniesta L, et al. Identification of a Western blot pattern for the specific diagnosis of Trypanosoma cruzi infection in human sera. Am J Trop Med Hyg 2012;86:412-6.
15. Piron M, Fisa R, Casamitjana N, et al. Development of a real-time PCR assay for Trypanosoma cruzi detection in blood samples. Acta Trop 2007;103:195-200.
16. Sabino EC, Lee TH, Montalvo L, et al. Antibody levels correlate with detection of Trypanosoma cruzi DNA by sensitive polymerase chain reaction assays in seropositive blood donors and possible resolution of infection over time. Transfusion 2013;53:1257-65.
17. Wendel S. Transfusion-transmitted Chagas' disease. Curr Opin Hematol 1998;5:406-11.
18. Rassi A Jr, Rassi A, Marin-Neto JA. Chagas disease. Lancet 2010;375:1388-402.
19. Piron M, Verges M, Muñoz J. Seroprevalence of Trypanosoma cruzi infection in at-risk blood donors in Catalonia (Spain). Transfusion 2007;48:1862-8.
20. Wincker P, Telleria J, Bosseno MF, et al. PCR-based diagnosis for Chagas' disease in Bolivian children living in an active transmission area: comparison with conventional serological and parasitological diagnosis. Parasitology 1997;114:367-73.
21. Schijman AG, Bisio M, Orellana L, et al. International study to evaluate PCR methods for detection of Trypanosoma cruzi DNA in blood samples from Chagas disease patients. PLoS Negl Trop Dis 2011;5:e931.
22. Dzib D, Hernandez VP, Ake BC, et al. Leukoreduction by centrifugation does not eliminate Trypanosoma cruzi from infected blood units. Vector Borne Zoonotic Dis 2009;9:235-41.
23. Coronado X, Ortiz S, Lastra O, et al. Instability of Trypanosoma cruzi DNA in blood lysates: importance for PCR DNA-based diagnosis. Mol Diagn 2005;9:35-40.
24. Hernandez-Becerril N, Mejía AM, Ballinas-Verdugo MA, et al. Blood transfusion and iatrogenic risks in Mexico City. Anti-Trypanosoma cruzi seroprevalence in 43,048 blood donors, evaluation of parasitemia, and electrocardiogram findings in seropositive. Mem Inst Oswaldo Cruz 2005;100:111-6.
25. Stramer SL, Hollinger FB, Katz LM, et al. Emerging infectious disease agents and their potential threat to transfusion safety. Transfusion 2009;49(Suppl 2):1S-29.
26. Martin DL, Goodhew B, Czaicki N, et al. Trypanosoma cruzi survival following cold storage: possible implications for tissue banking. PloS One 2014;9:e95398.
27. Amato NV, Matsubara L, Lanura PN. Avaliação do sistema quantitative buffy coat (QBC) no diagnostico laboratorial da infecção pelo Trypanosoma cruzi: estudo em modelo experimental murino. Rev Soc Bra Med Trop 1996;29:59-61.
28. Ferreira CS, Bezerra RC, Pinheiro AA. Methylene blue vital staining for Trypanosoma cruzi trypomastigotes and epimastigotes. Rev Inst Med Trop 2006;48:347-9.
29. Leiby DA, Lenes BA, Tibbals MA, et al. Prospective evaluation of a patient with Trypanosoma cruzi infection transmitted by transfusion. N Engl J Med 1999;341:1237-9.
30. Tonnetti L, Thorp AM, Reddy HL, et al. Evaluating pathogen reduction of Trypanosoma cruzi with riboflavin and ultraviolet light for whole blood. Transfusion 2012;52:409-16.
31. Cardo LJ, Salata J, Mendez J, et al. Pathogen inactivation of Trypanosoma cruzi in plasma and platelet concentrates using riboflavin and ultraviolet light. Transfus Apher Sci 2007;37:131-7.